Market Tracker

03/24 5:16pm ET

Exelixis Inc (NASDAQ:EXEL)

20.91
Delayed Data
As of 3:59pm ET
 +0.60 / +2.95%
Today’s Change
3.64
Today|||52-Week Range
23.49
+40.24%
Year-to-Date
Why Exelixis Is Already Up 55% This Year
Mar 15 / MotleyFool.com - Paid Partner Content
Top Stocks That Are Already Crushing the Market in 2017
Mar 13 / MotleyFool.com - Paid Partner Content
The 3 Most Important Numbers for Exelixis, Inc.
Mar 14 / MotleyFool.com - Paid Partner Content
3 Horrible Stocks for Retirees
Mar 12 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close20.31
Today’s open20.32
Day’s range20.31 - 21.08
Volume3,344,198
Average volume (3 months)5,560,205
Market cap$5.9B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+65.43%
Earnings growth (this year)+111.73%
Earnings growth (next 5 years)+46.00%
Revenue growth (last year)+415.05%
P/E ratioNM
Price/Sales19.51
Price/Book65.93

Competitors

 Today’s
change
Today’s
% change
ICLRICON PLC+1.34+1.73%
CRLCharles River Labora...+0.30+0.34%
PRAHPRA Health Sciences ...+1.92+3.21%
PRXLPAREXEL Internationa...+0.53+0.86%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$191.5M
Annual profit (last year)-$70.2M
Net profit margin-36.68%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts